drugset / Trial / NCT01460199
Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is being conducted to evaluate the safety and tolerability of treatment with CTP-499 in non-dialysis patients associated with moderate chronic kidney disease.
Timeline
- Start
- 2011-08
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTP-499 | Small molecule | 600 mg | — |